Lifecore Biomedical (LFCR) CEO Josephs received 38,461 shares
Insider transactions reported
Paul Josephs (Chief Executive Officer at Lifecore Biomedical Inc., LFCR) reported that they received 38,461 shares, and gave up 11,769 shares at $7.15 to cover taxes or an exercise price on Dec 6, 2024. After these transactions the filing shows 542,717 shares held directly.
- Reporting person
- Josephs Paul
- Role
- Chief Executive Officer
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Dec 6, 2024 | Grant or award (A) | Common Stock | +38,461 | - | - | 554,486 direct |
| Dec 6, 2024 | Shares withheld for taxes or exercise price (F) | Common Stock1 | -11,769 | $7.15 | $84.1K | 542,717 direct |
Holdings before and after
- Common Stock: 516,025 to 542,717 direct
Footnotes from the filing
- 1. Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the stock grant.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
- Shares withheld for taxes or exercise price:
- Code F marks shares handed back or withheld to pay taxes or an exercise price. No sale happens in the market.
FAQ
What did Josephs report in this LFCR Form 4?
Paul Josephs (Chief Executive Officer at Lifecore Biomedical Inc., LFCR) reported that they received 38,461 shares, and gave up 11,769 shares at $7.15 to cover taxes or an exercise price on Dec 6, 2024. After these transactions the filing shows 542,717 shares held directly.
How many LFCR shares does Josephs hold after this filing?
The filing shows 542,717 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for LFCR
Earlier insider filings at LFCR
- Dec 10, 2024Chief Financial Officer Lake Ryan David was granted 19,720 shares and covered exercise/tax liability with 5,653 shares, increasing direct ownership by 5% to 317,429 units (SEC Form 4)
- Oct 29, 2024Chief Financial Officer Lake Ryan David converted options into 75,000 shares and covered exercise/tax liability with 34,138 shares, increasing direct ownership by 16% to 303,362 units (SEC Form 4)
- Oct 8, 2024Large owner Wynnefield Partners Small Cap Value Lp I bought $1,200,000 worth of shares (292,683 units at $4.10) (SEC Form 4)
- Sep 16, 2024Amendment: Director Antunes Humberto Calheiros was granted 24,554 shares, increasing direct ownership by 818% to 27,554 units (SEC Form 4)
- Sep 5, 2024Chief Financial Officer Lake Ryan David was granted 262,500 shares (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow LFCR and get a push notification the moment its next story breaks.